Jindal Drugs Pvt Ltd

Jindal Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Jindal Drugs Pvt Ltd

₹ None%
- close price
Company website BSE: 531230
About
[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE 9.55 %
  • ROE 7.60 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • The company has delivered a poor sales growth of -18.4% over past five years.
  • Company has a low return on equity of 10.4% over last 3 years.
  • Earnings include an other income of Rs.72.2 Cr.
  • Working capital days have increased from 112 days to 163 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
364 536 414 1,101 955 940 866 311 319 400 340 314
335 497 410 991 820 801 807 274 289 327 232 249
Operating Profit 29 39 5 110 135 138 59 37 30 73 108 65
OPM % 8% 7% 1% 10% 14% 15% 7% 12% 9% 18% 32% 21%
9 30 33 25 38 19 38 31 36 131 52 72
Interest 0 1 2 36 11 20 6 4 2 3 2 5
Depreciation 9 13 9 11 15 18 25 16 17 16 14 13
Profit before tax 28 54 27 87 146 120 65 48 47 185 143 120
Tax % 12% 16% 22% 19% 21% 21% 20% 15% 14% 22% 22% 25%
25 46 21 71 116 95 52 41 41 145 111 90
EPS in Rs
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -5%
5 Years: -18%
3 Years: -1%
TTM: -8%
Compounded Profit Growth
10 Years: 7%
5 Years: 11%
3 Years: 31%
TTM: -20%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: 9%
5 Years: 8%
3 Years: 10%
Last Year: 8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity Capital 12 12 12 12 12 12 12 12 12 12 12 12
Reserves 407 453 474 545 661 757 809 948 848 993 1,104 1,194
39 113 97 108 152 155 143 158 8 120 44 196
24 35 26 43 95 71 64 94 147 155 156 153
Total Liabilities 482 613 609 707 920 995 1,028 1,212 1,015 1,280 1,316 1,555
110 100 94 107 162 171 253 238 162 148 135 124
CWIP 8 8 18 32 67 89 6 4 0 0 233 234
Investments 43 34 25 17 70 234 258 213 338 120 120 120
321 471 472 551 620 501 511 757 515 1,012 828 1,078
Total Assets 482 613 609 707 920 995 1,028 1,212 1,015 1,280 1,316 1,555

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
120 65 129 201 139 138 -9
0 -128 52 50 -355 -71 -178
0 0 11 -148 110 -78 147
Net Cash Flow 120 -63 191 104 -107 -10 -39

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Debtor Days 111 95 80 50 72 37 43 177 70 80 34 56
Inventory Days 36 28 28 26 41 67 96 199 74 122 158 192
Days Payable 9 11 6 5 24 16 7 20 7 13 17 11
Cash Conversion Cycle 137 111 102 71 88 88 131 356 137 189 175 238
Working Capital Days 216 158 190 92 110 117 159 396 123 105 68 163
ROCE % 6% 10% 5% 20% 21% 16% 8% 4% 5% 17% 13% 10%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports

No data available.